HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BORBA Enters Mass With Aspirations To Be "Synonymous With Innovation"

This article was originally published in The Rose Sheet

Executive Summary

California-based “beautyceutical” marketer BORBA plans to broaden its customer base with the national debut of a new line exclusively at Walgreens, representing the brand’s first foray into the mass-market channel.
Advertisement

Related Content

Attorney: FTC Put Industry “On Notice” With Nivea Case
High Expectations For Energy Drink Actives, Bee Venom In Skin Care
More Consumers Follow Green Instincts In Health-Care Product Choices
Improving Credibility Key To Nutricosmetic Success In U.S. – Datamonitor
Improving Credibility Key To Nutricosmetic Success In U.S. – Datamonitor
Euromonitor Predicts Growth For Firms Offering "Sophistication" At Mass
Euromonitor Predicts Growth For Firms Offering "Sophistication" At Mass
Borba Teams With Brewer To Market Drinkable Skin Care; QVC Owner Invests
Borba Teams With Brewer To Market Drinkable Skin Care; QVC Owner Invests
BORBA Skin Care Growth Plan Includes Advertising Initiative
Advertisement
UsernamePublicRestriction

Register

RS017413

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel